| Old Articles: <Older 5411-5420 Newer> |
 |
The Motley Fool January 25, 2005 Nathan Slaughter |
Sara Lee Slimming Down Has the conglomerate, which reduced its second-half outlook, lost its way? Investors should allow for a little more patience as the company works through sluggish conditions.  |
The Motley Fool January 25, 2005 Tim Beyers |
Sell EMC? Nope, Not Me Investors are selling stock in the storage king. Why?  |
The Motley Fool January 25, 2005 Stephen D. Simpson |
Prognosis Good for Merck The pharmaceutical weathered a tough year but should ride out its Vioxx troubles. While strict value investors may be put off, risk-tolerant investors can buy these shares today.  |
The Motley Fool January 25, 2005 Charly Travers |
Grading Old-School Biotech Be very wary of biotech IPOs from companies lacking drugs.  |
The Motley Fool January 25, 2005 Stephen D. Simpson |
Oshkosh My Gosh Specialty vehicle maker Oshkosh Truck defies high materials costs with a great quarter. With strong returns on equity and assets and the ability to generate real free cash flow from the business, Oshkosh just might keep the sirens blowing for some time to come.  |
The Motley Fool January 25, 2005 Ben McClure |
palmOne Two Palms Lighter The CEO's resignation likely means more trouble ahead. The stock fell another 5% this morning.  |
The Motley Fool January 25, 2005 Rich Smith |
ViaCell's Costly Mistake Cord blood harvester neglects to collect the cash with an undervalued IPO.  |
The Motley Fool January 25, 2005 Stephen D. Simpson |
Schering-Plough Turning a Corner The troubled pharmaceutical company begins to show signs of life. Investors looking for a more stable play would do well to look at other shares instead.  |
The Motley Fool January 25, 2005 Stephen D. Simpson |
Bringing Baywatch to Central Europe Acquisition of Czech TV station should catapult Central European Media into prime time. From trading over the counter for less than a quarter per share back in 2000, CME stock has come back to a lofty perch.  |
The Motley Fool January 25, 2005 David Gardner |
How Marvel Makes Money Marvel's vice chairman, Peter Cuneo, speaks about his company's prospects and future. This is the second of five parts.  |
| <Older 5411-5420 Newer> Return to current articles. |